1. Efficacy and safety of the mRNA‐1273 SARS‐CoV‐2 vaccine;Baden;N Engl J Med,2021
2. Safety and immunogenicity of the ChAdOx1 nCoV‐19 vaccine against SARS‐CoV‐2: a preliminary report of a phase 1/2, single‐blind, randomised controlled trial;Folegatti;Lancet,2020
3. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford‐AstraZeneca ChAdOx1‐S in Denmark and Norway: population based cohort study;Pottegård;BMJ,2021
4. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 20.6 million people in six European countries;Burn;medRxiv,2021
5. MHRA. Coronavirus vaccine – weekly summary of Yellow Card reporting (Updated 14 October 2021). 2021. https://www.gov.uk/government/publications/coronavirus‐covid‐19‐vaccine‐adverse‐reactions/coronavirus‐vaccine‐summary‐of‐yellow‐card‐reporting